Award-winning health tech company DrDoctor has raised £3,000,000 Series A Round investment from venture capital firms Ananda Impact Ventures and 24Haymarket. The money will be used to hire across the business and add new functionality to DrDoctor’s patient communication platform, which transforms the way hospitals communicate with their patients, ensuring fewer missed appointments across the NHS, lower administrative costs for hospitals and clinics, and more timely care for patients.

HomeDoctor, a Warsaw and Amsterdam-based digital healthcare provider has announced a €3,7m Series A funding round led by Cogito Capital Partners with participation from the Company’s founders. HomeDoctor, founded in 2016, is a leader in the Polish market in providing online medical consultations and delivery of healthcare services to patients’ homes. The Company is operating as a b2b2c and a b2c medical services platform that enables delivery of both, online and phone consultations (telemedicine channel) and booking a doctor appointment (home visit).

Panthera Biopartners has completed a Series A funding round with Gresham House Ventures as a major investor. The capital raised will enable Panthera to further build out its network of clinical trial sites across the UK and overseas and increase its team of clinical trial experts in serving both pharma and patients.

Panthera Biopartners has completed a Series A funding round with Gresham House Ventures as a major investor. The capital raised will enable Panthera to further build out its network of clinical trial sites across the UK and overseas and increase its team of clinical trial experts in serving both pharma and patients.

Dublin start-up FoodMarble has raised €1.2M in a funding round which included HBAN business angels from the MedTech syndicate who invested alongside Enterprise Ireland, SOSV and Delta Partners. The investment will support the company's ongoing research and development, along with expansion into the US and Canada.

Deepbridge Capital and Boundary Capital backed diagnostics firm Glyconics® has been awarded an internationally recognised quality certification for the development of its diagnostic medical devices product range.

Ceryx Medical, a bioelectronics startup working towards the world’s first curative therapy for heart failure, has secured a £575,000 seed round.

The funding, which comprises a £250,000 commitment from the Development Bank of Wales, £225,000 from angel investors, and £100,000 from the University of Bristol’s Enterprise Investment Fund, managed by leading UK university spinout investor ParkWalk, will enable the company to grow its management and technology teams.

The Advanced Therapy Treatment Centre (ATTC) network has been awarded a total of £9.5 million to fund an additional 12 months of the programme. £6.5 million has been granted from the Government's Department for Business, Energy and Industrial Strategy (BEIS) and an additional £3 million from its Industrial Strategy Challenge Fund (ISCF), managed by UK Research and Innovation (UKRI). The funding will support additional initiatives through to March 2022 and continuation of certain centre and network projects which were impacted by the COVID-19 pandemic. This award builds upon the significant success of the ATTC network to date. The UK accounts for 12% of global advanced therapy medicinal product (ATMP) clinical trials and the network supports half of those.

Crista Galli Ventures, a new early-stage healthtech fund that offers patient capital and deep healthcare expertise, has launched this week.  Crista Galli Ventures partners with early-stage founders at Seed and Series A to build world-leading companies, and has tailored its strategy to the needs of ambitious healthtech entrepreneurs, and the unique industry in which they operate.

UK-based start-up Skin Analytics has raised £4 million in Series A funding. The funding round was led by Hoxton Ventures with participation from Nesta and Mustard Seed Ventures.

Asklepios BioPharmaceutical, Inc., a leading, clinical-stage gene therapy company dedicated to developing adeno-associated virus (AAV) gene therapies for genetic disorders, has been awared a £1.99m R&D Grant from Scottish Enterprise.

AskBio will invest £3.4m alongside the grant to fund research into the manufacturing challenges associated with scaling gene therapies for widespread patient access, to further develop technologies to improve the safety and efficacy of current therapies, and to enable the treatment of genetic diseases with more complicated disease pathways that the industry is not yet able to address.

ClinSpec Diagnostics, a university spin-out which has developed a way to detect cancer at an early stage using a simple blood test, has completed a £2.4m funding round led by Mercia’s EIS funds.